The University of Michigan's Department of Pathology and Genetics Squared have collaborated on applying GP to cancer expression profiling.Yu et al. Neoplasia 9(4): 292-303, 2007 Feature Selection and Molecular Classification of Cancer Using Genetic Programming
Professor Stephen B. Gruber, M.D., Ph.D., M.P.H of The University of Michigan School of Public Health and Genetics Squared are collaborating to obtain tissue samples for use in development of novel diagnostic and prognostic tests related to cancer.
Sanford Health
Biobank
Genetics Squared, Inc., in collaboration with Asterand plc, has submitted a detailed plan to Sanford Health of Sioux Falls, South Dakota outlining the establishment of a bio-bank that will provide important tissue samples to Sanford’s research staff and to research institutions around the world. The bio-bank is essential for translational research using genetic, genomic and proteomic tools to develop novel diagnostic and therapeutic technologies
Sanford Project
Genetics Squared’s Chief Medical Officer, Dr. Peter Lenehan, participated in the Sanford Project Advisory Council whose recommendations will influence $400 Million in research funding. The Sanford Project will focus on a single pressing healthcare issue and establish a world class research team dedicated to finding a cure for a disease to be chosen by the Sanford Health. The Sanford Project is one of four initiatives outlined by Sanford Health of Sioux Falls, South Dakota after a gift of $400 million by Mr. T. Denny Sanford in February 2007. The gift is the largest ever to a healthcare organization or hospital in America.
In all, over 60 experts from various disease advocacy and research groups were consulted and 15 formal proposals were narrowed down to the final four that were presented to the Advisory Council. Each of the thirteen Advisory Council members was chosen based on their broad experience in health research, disease, and translational medicine. Participants included senior executives, medical practitioners, researchers, and regulatory experts from industry, academia, clinical institutions, and the NIH.
Sanford Health is one of the few truly integrated, comprehensive health systems in the nation. Sanford believes its comprehensive, integrated and non-profit system model is the best and most sustainable way to deliver high quality and efficient healthcare. Sanford Health includes Sanford USD Medical Center, Sanford Clinic, Sanford Health Network, Sanford Health Plan and Sanford Health Foundation, all serving communities in South Dakota, Minnesota, Iowa and Nebraska.
University of Southern California, Department of Pathology
Genetics Squared and USC have partnered to develop a prognostic test for the identification of nodal status in bladder cancer. Mitra AP, et al. The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer. BMC Cancer, 6:159 (Jun 16), 2006
Netherlands Organization for Applied Scientific Research (TNO), Voeding, Zeist, The Netherlands
Genetics Squared and TNO have partnered to develop a test kit that differentiates known pathogenic strains of Legionella from environmental strains. New: Schuren et al. Identification of predictive markers for Legionella pneumophila pathogenicity. Poster (pdf) Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 17-20, Chicago. New: This work is the basis for the Legyon water test kit described here.
AND Case study available on Using Genetics Squared’s EvolverTM Technology to Identify Predictive
Biomarkers for Legionella pneumophila Pathogenicity
Asterand, plc
Consequent to winning a $1.6 million award from the Michigan 21st Century Job Fund, Genetics Squared and Asterand have partnered to develop prognostic tests for colorectal cancer. |
